Haima Li
Xianyang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Single-cell atlas of photoaged skin reveals JAK-STAT blockade as a strategy to reverse dermal remodeling.
Journal: Frontiers in immunology
Published: November 17, 2025
Paeoniflorin inhibits glioblastoma proliferation and promotes autophagy through the AKT/mTOR pathway.
Journal: Scientific reports
Published: March 01, 2025
SKP2 protein as a prognostic biomarker for glioma and promotes tumor progression by regulating the cell cycle.
Journal: Scientific reports
Published: February 27, 2025
Propofol-related infusion syndrome happened in a non-critically ill perioperative young patient: A case report.
Journal: SAGE open medical case reports
Published: December 04, 2024
Platycodin D Enhances Glioma Sensitivity to Temozolomide by Inhibition of the Wnt/β-Catenin Pathway.
Platycodin D Enhances Glioma Sensitivity to Temozolomide by Inhibition of the Wnt/β-Catenin Pathway.
Journal: Drug design, development and therapy
Published: December 03, 2024
DEP domain‑containing 1 is a prognostic biomarker associated with the cell cycle in gliomas.
Journal: Oncology letters
Published: August 09, 2024
Roles of DEPDC1 in various types of cancer (Review).
Journal: Oncology letters
Published: April 24, 2024
Platycodin D inhibits glioblastoma cell proliferation, migration, and invasion by regulating DEPDC1B-mediated epithelial-to-mesenchymal transition.
Journal: European journal of pharmacology
Published: June 24, 2023
Platycodin D suppresses proliferation, migration, and invasion of human glioblastoma cells through regulation of Skp2.
Journal: European journal of pharmacology
Published: November 25, 2022
Showing 1-10 of 10
Last Updated: 09/26/2026